Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

NCT00488761 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii

NCT01342731 ·Status: UNKNOWN ·Phase: PHASE4

A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely

NCT00368498 ·Status: UNKNOWN ·Phase: PHASE4

Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

NCT00368537 ·Status: COMPLETED ·Phase: PHASE4

Clinical Effectiveness of a Once-daily Regimen of Tigecycline Compared to the Standard Regimen

NCT07258225 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Tygacil Drug Use Investigation

NCT01789905 ·Status: COMPLETED

Clinical Evaluation of the Residual Antimicrobial Activity

NCT04495920 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Pharmacokinetic Study of Linezolid for TB Meningitis

NCT03537495 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

NCT00002085 ·Status: COMPLETED ·Phase: NA

TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis

NCT00523926 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge

NCT01222832 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections

NCT06990126 ·Status: ENROLLING_BY_INVITATION

PK/PD of Ertapenem In Patients With TB

NCT01730664 ·Status: COMPLETED ·Phase: PHASE2

Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice

NCT01212601 ·Status: COMPLETED

Antibiotics and Vaccine Immune Responses Study

NCT06148025 ·Status: RECRUITING ·Phase: PHASE4

Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms

NCT01671358 ·Status: COMPLETED

Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease

NCT00004689 ·Status: COMPLETED ·Phase: PHASE2

Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis

NCT01169038 ·Status: COMPLETED ·Phase: PHASE1

In Vitro Activity of Ceftolozane/Tazobactam and Imipenem/Relebactam in Clinical Isolates of Pseudomonas Aeruginosa and Enterobacterales Collected From Hematology and Oncology Patients

NCT04196608 ·Status: UNKNOWN

Predictors of Antimicrobial Resistance in the Respiratory Intensive Care Unit of Alexandria Main University Hospital

NCT06750744 ·Status: COMPLETED

Nasal Swab Study to Explore the Nasal Microbia

NCT02535442 ·Status: COMPLETED

A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA)

NCT01158235 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

NCT05979545 ·Status: RECRUITING ·Phase: PHASE4

COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

NCT05020145 ·Status: COMPLETED

A Study of Comparing Safety and Reactogenicity, of Lyophilized BCG Vaccine IP of Green Signal Bio Pharma Private Limited, India With BCG Vaccine of Serum Institute of India Limited in 120 Healthy Children.

NCT01250249 ·Status: COMPLETED ·Phase: PHASE3